<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81631">
  <stage>Registered</stage>
  <submitdate>4/10/2006</submitdate>
  <approvaldate>23/11/2006</approvaldate>
  <actrnumber>ACTRN12606000480583</actrnumber>
  <trial_identification>
    <studytitle>Parecoxib for postoperative pain after minor gynaecological surgery</studytitle>
    <scientifictitle>Single dose parecoxib for pain relief following dilatation and curettage and/or hysteroscopy</scientifictitle>
    <utrn />
    <trialacronym>The COMFIT study</trialacronym>
    <secondaryid>1282/EP</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain following dilatation and currettage and/or hystersocopy</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Randomised double blind placebo-controlled parallel group study of a single intraoperative dose of intravenous parecoxib 40 mg versus saline placebo</interventions>
    <comparator>Single intraoperative dose of intravenous saline placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>0 - 10 cm numerical rating scale pain score with movement</outcome>
      <timepoint>At one hour postoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pain score </outcome>
      <timepoint>at rest 1 hour postop</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Pain score </outcome>
      <timepoint>at 2 and 24 hours postop</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first use of postoperative intravenous fentanyl analgesia</outcome>
      <timepoint>as occurs up until discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first use of postoperative oral tramadol analgesia</outcome>
      <timepoint>as occurs until discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total dose of intravenous fentanyl </outcome>
      <timepoint>at discharge from recovery room</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total dose of oral tramadol </outcome>
      <timepoint>at 24 h postop</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Nausea/vomiting incidence </outcome>
      <timepoint>at 24 h postop</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Headache incidence </outcome>
      <timepoint>at 24 h postop</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of recovery (QoR)score </outcome>
      <timepoint>at 24 hour postop </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health outcomes recovery (H.O.R) questionnaire score </outcome>
      <timepoint>at 24 hour postop </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Satisfaction score </outcome>
      <timepoint>at 24 h postop</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>American Society of Anesthesiologists (ASA) physical status classifiaction I or II Undergoing dilatation and curettage +/- hysteroscopy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Renal dysfunction Hypertension History of sulphonamide allergy Unsuitable for general anaesthesia with maintenance by inhalational agent Use of suxamethonium Preoperative use of NSAID or opiate analgesics</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>simple computer derived randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Subjects,assessors and data analysts are blinded</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/09/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>90</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>individual (Kate Luscombe)</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesia and Pain Medicine, king Edward Memorial Hospital for Women, 374 bagot rd Subiaco WA 6008</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>King Edward Memorial Hospital for Women Department of Anaesthesia and Pain Medicine</fundingname>
      <fundingaddress>374 Bagot Rd Subaiaco WA 6008</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to find out if giving a single dose of parecoxib intravenously in theatre improves pain relief following surgery for dilatation and curettage with or without  hysteroscopy.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>King Edward Memorial Hospital for Women</ethicname>
      <ethicaddress />
      <ethicapprovaldate>4/07/2006</ethicapprovaldate>
      <hrec>EC06-41</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Nolan McDonnell</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd
Subiaco WA 6008</address>
      <phone>+61 8 93402222</phone>
      <fax>+61 8 93402260</fax>
      <email>nolan.mcdonnell@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd
Subiaco WA 6008</address>
      <phone>+61 8 93402222</phone>
      <fax>+61 8 93402260</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>